Previous studies have demonstrated that GLP-1R agonist inhibits NOX4-mediated ROS production in high-glucose cultured endothelial cells or angiotensin II-induced cardiac hypertrophy [37,38]. Here, NOX4 is linked to cardiac hypertrophy.